Paxlovid may not significantly benefit vaccinated seniors, study says
By Alice Park Senior Correspondent
We've all become more adept at managing COVID-19, from recognizing its symptoms to testing ourselves and seeking out antiviral treatments like Paxlovid. But since the initial studies on that drug were done, one major thing has changed: Most people in the U.S. are now vaccinated.
So how effective is Paxlovid in vaccinated people who are also at high risk of severe COVID-19? Here's what researchers recently learned.
Here Are Trump's Major Moves on Reproductive Health Access
In his first month in office, Trump has taken several actions affecting reproductive healthcare access.
Why Walking Isn't Enough When It Comes to Exercise
Walking is great, but it can only take you so far.
7 Things to Say When Someone Gaslights You
We asked experts what to say and why it works.
If you were forwarded this and want to sign up to receive it daily, click here. Today's newsletter was written by Alice Park and edited by Angela Haupt.
Comentarios
Publicar un comentario